Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avonex in Moderate to Severe Ulcerative Colitis
NCT00616434Phase 2Completed
- Sponsor
- Biogen
- Start
- May 2008
- Primary completion
- Mar 2010
- Modality
- Cytokines & Interferons
- Countries
- 7
01
Overview
A Phase 2 trial of interferon beta-1a in ulcerative colitis (UC), sponsored by Biogen. Started May 2008; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00616434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00616434.